13F-HR: CVS Health Corp Discloses Equity Holdings in Latest 13F Filing

CVS Health Corp's recent 13F filing reveals its holdings in Prudential Financial, Health Catalyst, and SPDR S&P 500 ETF Trust as of December 31, 2024.

Summary

• CVS Health Corp filed its Form 13F holdings report for the quarter ended December 31, 2024.
• The filing discloses holdings in three entities: Prudential Financial Inc, Health Catalyst Inc, and SPDR S&P 500 ETF Trust.
• The total value of the reported holdings amounts to $233,742,140.
• The report indicates sole voting authority for all shares held.

Sentiment

Score: 6

Explanation: The document is a standard regulatory filing, so the sentiment is neutral. It provides factual information about the company's holdings.

Positives

• The filing provides transparency into CVS Health Corp's investment portfolio.
• The significant investment in SPDR S&P 500 ETF Trust suggests a focus on broad market exposure.

Industry Context

Institutional investment managers are required to file Form 13F to disclose their equity holdings, providing insights into investment trends and strategies of major players in the market.

Comparison to Industry Standards

• Form 13F filings are a standard practice for institutional investment managers with over $100 million in assets under management, as mandated by the SEC.
• Comparing CVS Health Corp's holdings to those of other healthcare companies or diversified investment firms could reveal insights into their investment strategies and risk profiles.
• Analyzing the allocation percentages across different asset classes (e.g., equities, ETFs) can provide a benchmark against industry averages.

Stakeholder Impact

• Shareholders can use this information to understand CVS Health Corp's investment strategy.
• The holdings in other companies may impact those companies' shareholders as well.

Key Dates